New NIH Bioscience "Stimulus" Grants Deadline April 27
Bioscience researchers throughout North Carolina have until April 27 to submit proposals to the National Institutes of Health for grants worth up to $500,000 a year each -- $1 million over the two-year project period -- coming from the federal economic stimulus package.
NIH has kicked off its stimulus package spending with the new Challenge Grants program, containing at least $200 million for distribution in fiscal years 2009 and 2010. It's expected to fund 200 or more grants from applicants who get their proposals in before the end of April 2009.
The challenge grants will have special application and review processes aimed at creating a fast track for getting the labs going, outfitted, and staffed. Targeted areas of research include genomics, biomarker studies, translational science, comparative effectiveness research, and bioethics studies of problems facing contemporary medical research and practices.
The program will support research on topic areas that address specific scientific and health research challenges in biomedical and behavioral research that would benefit from significant two-year jumpstart funds, according to the National Human Genome Research Institute.
The Challenge Grants program will fund a wide array of genomics and genetics-related research. They will be used to augment genome-wide association studies; to discover genetic factors affecting disease risk with age; to plan genome-wide studies of oral, cranio-facial, and joint disorders; to study the genomics of complex eye disorders; to develop high-throughput technologies; to identify genetic variants linked to heart, lung, and blood diseases using DNA capture and massively parallel sequencing and selective genotyping; and to pursue other genomics and disease research.
Researchers involved in biomarker-related research may apply for funds in a number of areas including biomarkers related to damage after acute joint injury; identifying biomarkers to assess the impact of stress, social, biological, and immune functions; developmental studies of biomarkers for oxidative stress in order to assess the antioxidant effects of dietary supplements; the establishment of pain biomarkers and measurements to advance our understanding of pain mechanisms; to develop novel molecular targets from unsuccessful medication trials; developing biosignatures for drug exposure; developing new mass spectrometry technologies; and other research areas.